동성제약
002210KOSPI의약품 제조업37.3 / 100
Reference Date: 2026-07-24
Company InformationBased on 2025 Annual Report
Business Overview
Dongseong Pharmaceutical operates 13 facilities across South Korea, with headquarters in Seoul, and is divided into three business segments: pharmaceuticals, hair dyes, and cosmetics. Key products include Jeongrohwan, Seven Eight, and Lances, with pharmaceuticals and hair dyes produced in-house at the Asan plant, while cosmetics are sold through purchased goods.
Number of Employees
307people
Average Salary
42.6M KRW
Score Calculation Basis
Detailed Financial Score
5.0x industry avg (risky)
Well below industry avg
5.3x industry avg (risky)
Avg ▼0.8% (2-year basis)
Avg ▼629.5% (2-year basis)
Avg ROE -32.2% (declining, 3yr)
Detailed News Sentiment
- Positive“살 빠지니 毛도 빠졌다”… 비만치료제 인기에 남몰래 웃는 탈모·헤.....
GLP-1 계열 비만치료제 인기 상승으로 동성제약의 탈모 및 헤어케어 제품 매출이 증가하고 있다.
- Neutral"내가 쓰던 모기향도 혹시?"…7월부터 미승인 살충제 ‘퇴출’
New regulations on pesticide approvals may affect supply chains but do not directly impact 동성제약's operations.
- Negative모기철 앞두고 약국들이 발칵 뒤집힌 이유
정부의 새로운 규제로 인해 동성제약의 관련 제품 판매 제한이 예상되어 부정적 영향이 우려됩니다.
Detailed Momentum
52w mid range (50%)
1m 0% (flat)
Volume flat
Detailed Disclosure
- Neutral기타시장안내 (상장적격성 실질심사 사유 추가 관련 안내)2026-07-15
- Negative불성실공시법인지정2026-07-15
